---
title: "COFOE: Has launched its first ventilator mask and plans to launch a new generation of ventilators next year"
type: "News"
locale: "en"
url: "https://longbridge.com/en/news/263631130.md"
description: "On October 30th, COFOE stated during an institutional research that the company has recently launched its first ventilator mask in terms of new product development and plans to successively launch multiple masks and a new generation of ventilator products next year. The new generation of ventilators features multiple functions such as intelligent pressure adjustment, automatic temperature and humidity regulation, blood oxygen and sleep monitoring, and supports APP and cloud connectivity, which will further improve the company's intelligent respiratory ecosystem and fill the gap in the high-end market"
datetime: "2025-10-31T01:01:17.000Z"
locales:
  - [zh-CN](https://longbridge.com/zh-CN/news/263631130.md)
  - [en](https://longbridge.com/en/news/263631130.md)
  - [zh-HK](https://longbridge.com/zh-HK/news/263631130.md)
generator: "portal-rs"
---

# COFOE: Has launched its first ventilator mask and plans to launch a new generation of ventilators next year

On October 30th, COFOE stated during an institutional research that the company has recently launched its first ventilator mask in terms of new product development and plans to successively launch multiple masks and a new generation of ventilator products next year. The new generation of ventilators features multiple functions such as intelligent pressure adjustment, automatic temperature and humidity regulation, blood oxygen and sleep monitoring, and supports APP and cloud connectivity, which will further improve the company's intelligent respiratory ecosystem and fill the gap in the high-end market

### Related Stocks

- [301087.CN](https://longbridge.com/en/quote/301087.CN.md)

## Related News & Research

- [ZAWYA: Saudi Red Sea kicks off operation of giant off-grid renewable energy system](https://longbridge.com/en/news/298394458.md)
- [Viromed Medical’s Heike Perbandt, closely associated with managing body member Uwe Perbandt, sells shares for EUR 52,000](https://longbridge.com/en/news/298227013.md)
- [SynAct Pharma bolsters resomelagon data as it readies Phase 3 and weighs strategic deals](https://longbridge.com/en/news/298195637.md)
- [EWG: Double-digit revenue growth and digital platform adoption drive robust margins and returns](https://longbridge.com/en/news/298417346.md)
- [Eurofins Scientific CEO-controlled Analytical Bioventures buys EUR 218,458 of shares](https://longbridge.com/en/news/298342552.md)

---
> **Disclaimer: This article is for reference only and does not constitute any investment advice.**